These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Failure of ursodeoxycholic acid to prevent acute cellular rejection after liver transplantation. Pageaux GP; Blanc P; Perrigault PF; Navarro F; Fabre JM; Souche B; Domergue J; Larrey D; Michel H J Hepatol; 1995 Aug; 23(2):119-22. PubMed ID: 7499781 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis. Zhang Y; Li S; He L; Wang F; Chen K; Li J; Liu T; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Xia Y; Zhou Y; Lu J; Guo C Drug Des Devel Ther; 2015; 9():2757-66. PubMed ID: 26045661 [TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646 [TBL] [Abstract][Full Text] [Related]
17. Urosdeoxycholic acid in primary sclerosing cholangitis: a meta-analysis and systematic review. Othman MO; Dunkelberg J; Roy PK Arab J Gastroenterol; 2012 Sep; 13(3):103-10. PubMed ID: 23122450 [TBL] [Abstract][Full Text] [Related]
18. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499 [TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials. Chen X; Yan XR; Zhang LP Medicine (Baltimore); 2018 Nov; 97(45):e13086. PubMed ID: 30407311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]